Literature DB >> 30416582

QT Prolongation and Malignant Arrhythmia: How Serious a Problem?

Christos-Konstantinos Antoniou1, Polychronis Dilaveris1, Panagiota Manolakou2, Spyridon Galanakos1, Nikolaos Magkas1, Konstantinos Gatzoulis1, Dimitrios Tousoulis1.   

Abstract

QT prolongation constitutes one of the most frequently encountered electrical disorders of the myocardium. This is due not only to the presence of several associated congenital syndrome but also, and mainly, due to the QT-prolonging effects of several acquired conditions, such as ischaemia and heart failure, as well as multiple medications from widely different categories. Propensity of repolarization disturbances to arrhythmia appears to be inherent in the function of and electrophysiology of the myocardium. In the present review the issue of QT prolongation will be addressed in terms of pathophysiology, arrhythmogenesis, treatment and risk stratification approaches. Although already discussed in literature, it is hoped that the mechanistic approach of the present review will assist in improved understanding of the underlying changes in electrophysiology, as well as the rationale for current diagnostic and therapeutic approaches.

Entities:  

Keywords:  QT prolongation; action potential duration; long QT syndromes; restitution curve; sudden cardiac death

Year:  2017        PMID: 30416582      PMCID: PMC6223357          DOI: 10.15420/ecr.2017:16:1

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  100 in total

Review 1.  Assessing QT prolongation and electrocardiography restitution using a beat-to-beat method.

Authors:  Anthony A Fossa; Meijian Zhou
Journal:  Cardiol J       Date:  2010       Impact factor: 2.737

Review 2.  Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?

Authors:  B Surawicz
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

3.  Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study.

Authors:  Z Qu; J N Weiss; A Garfinkel
Journal:  Am J Physiol       Date:  1999-01

4.  Identification of Concealed and Manifest Long QT Syndrome Using a Novel T Wave Analysis Program.

Authors:  Alan Sugrue; Peter A Noseworthy; Vaclav Kremen; J Martijn Bos; Bo Qiang; Ram K Rohatgi; Yehu Sapir; Zachi I Attia; Peter Brady; Samuel J Asirvatham; Paul A Friedman; Michael J Ackerman
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-07

Review 5.  Mechanisms of drug induced QT interval prolongation.

Authors:  Marcelo Luis Ponte; Guillermo Alberto Keller; Guillermo Di Girolamo
Journal:  Curr Drug Saf       Date:  2010-01

Review 6.  Insulin: new roles for an ancient hormone.

Authors:  E Ferrannini; A Q Galvan; A Gastaldelli; S Camastra; A M Sironi; E Toschi; S Baldi; S Frascerra; F Monzani; A Antonelli; M Nannipieri; A Mari; G Seghieri; A Natali
Journal:  Eur J Clin Invest       Date:  1999-10       Impact factor: 4.686

Review 7.  Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts.

Authors:  P Brugada; R Brugada; J Brugada; P Geelen
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

8.  ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome.

Authors:  A J Moss; W Zareba; J Benhorin; E H Locati; W J Hall; J L Robinson; P J Schwartz; J A Towbin; G M Vincent; M H Lehmann
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

9.  A molecular mechanism for adrenergic-induced long QT syndrome.

Authors:  Jie Wu; Nobu Naiki; Wei-Guang Ding; Seiko Ohno; Koichi Kato; Wei-Jin Zang; Brian P Delisle; Hiroshi Matsuura; Minoru Horie
Journal:  J Am Coll Cardiol       Date:  2013-10-30       Impact factor: 24.094

Review 10.  Electrophysiological mechanisms of long and short QT syndromes.

Authors:  Gary Tse; Yin Wah Fiona Chan; Wendy Keung; Bryan P Yan
Journal:  Int J Cardiol Heart Vasc       Date:  2016-11-26
View more
  9 in total

1.  Prediction of arrhythmia susceptibility through mathematical modeling and machine learning.

Authors:  Meera Varshneya; Xueyan Mei; Eric A Sobie
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

2.  Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System.

Authors:  Verena Charwat; Bérénice Charrez; Brian A Siemons; Henrik Finsberg; Karoline H Jæger; Andrew G Edwards; Nathaniel Huebsch; Samuel Wall; Evan Miller; Aslak Tveito; Kevin E Healy
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-29

3.  Mechanistic Insights Into Inflammation-Induced Arrhythmias: A Simulation Study.

Authors:  Xiangpeng Bi; Shugang Zhang; Huasen Jiang; Wenjian Ma; Yuanfei Li; Weigang Lu; Fei Yang; Zhiqiang Wei
Journal:  Front Physiol       Date:  2022-05-30       Impact factor: 4.755

Review 4.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

5.  Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients.

Authors:  Nicolas Ansermot; Meredith Bochatay; Jürg Schläpfer; Mehdi Gholam; Ariane Gonthier; Philippe Conus; Chin B Eap
Journal:  Ther Adv Psychopharmacol       Date:  2019-12-12

6.  Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study.

Authors:  Ari Pelli; M Juhani Junttila; Tuomas V Kenttä; Simon Schlögl; Markus Zabel; Marek Malik; Tobias Reichlin; Rik Willems; Marc A Vos; Markus Harden; Tim Friede; Christian Sticherling; Heikki V Huikuri
Journal:  Europace       Date:  2022-05-03       Impact factor: 5.486

7.  The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort.

Authors:  Cenk Babayigit; Nurdan Kokturk; Seval Kul; Pelin Duru Cetinkaya; Sibel Atis Nayci; Serap Argun Baris; Oguz Karcioglu; Pinar Aysert; Ilim Irmak; Aycan Akbas Yuksel; Yonca Sekibag; Oya Baydar Toprak; Emel Azak; Sait Mulamahmutoglu; Caglar Cuhadaroglu; Aslihan Demirel; Bugra Kerget; Burcu Baran Ketencioglu; Hasan Selcuk Ozger; Gulcihan Ozkan; Zeynep Ture; Begum Ergan; Vildan Avkan Oguz; Oguz Kilinc; Merve Ercelik; Tansu Ulukavak Ciftci; Ozlem Alici; Esra Nurlu Temel; Ozlem Ataoglu; Asena Aydin; Dilek Cetiner Bahcetepe; Yusuf Taha Gullu; Fusun Fakili; Figen Deveci; Neslihan Kose; Muge Meltem Tor; Gulsah Gunluoglu; Sedat Altin; Teyfik Turgut; Tibel Tuna; Onder Ozturk; Oner Dikensoy; Pinar Yildiz Gulhan; Ilknur Basyigit; Hasim Boyaci; Ipek Kivilcim Oguzulgen; Sermin Borekci; Bilun Gemicioglu; Firat Bayraktar; Osman Elbek; Ismail Hanta; Hacer Kuzu Okur; Gulseren Sagcan; Oguz Uzun; Metin Akgun; Goksel Altinisik; Berna Dursun; Ebru Cakir Edis; Erkmen Gulhan; Fusun Oner Eyuboglu; Okkes Gultekin; Yavuz Havlucu; Metin Ozkan; Aysin Sakar Coskun; Abdullah Sayiner; A Fuat Kalyoncu; Oya Itil; Hasan Bayram
Journal:  Front Med (Lausanne)       Date:  2022-08-31

Review 8.  Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.

Authors:  Kalina Andrysiak; Jacek Stępniewski; Józef Dulak
Journal:  Pflugers Arch       Date:  2021-02-24       Impact factor: 3.657

9.  Evaluation of the Safety and Efficacy of Teneligliptin at a Higher Dose in Indian Type 2 Diabetes Patients: A Retrospective Analysis.

Authors:  Asis Mitra; Saswati Ray
Journal:  Cureus       Date:  2020-01-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.